WO2002016602A3 - Compositions and methods for the diagnosis and treatment of tumor - Google Patents

Compositions and methods for the diagnosis and treatment of tumor Download PDF

Info

Publication number
WO2002016602A3
WO2002016602A3 PCT/US2001/026626 US0126626W WO0216602A3 WO 2002016602 A3 WO2002016602 A3 WO 2002016602A3 US 0126626 W US0126626 W US 0126626W WO 0216602 A3 WO0216602 A3 WO 0216602A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
tumor
diagnosis
treatment
methods
Prior art date
Application number
PCT/US2001/026626
Other languages
French (fr)
Other versions
WO2002016602A2 (en
Inventor
Avi J Ashkenazi
Audrey Goddard
Paul J Godowski
Austin L Gurney
Paul Polakis
P Mickey Williams
William I Wood
Thomas D Wu
Zemin Zhang
Original Assignee
Genentech Inc
Avi J Ashkenazi
Audrey Goddard
Paul J Godowski
Austin L Gurney
Paul Polakis
P Mickey Williams
William I Wood
Thomas D Wu
Zemin Zhang
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2000/023328 external-priority patent/WO2001016318A2/en
Priority claimed from PCT/US2000/032678 external-priority patent/WO2001040466A2/en
Priority claimed from PCT/US2001/006520 external-priority patent/WO2001068848A2/en
Priority claimed from PCT/US2001/017800 external-priority patent/WO2001093983A1/en
Priority claimed from PCT/US2001/019692 external-priority patent/WO2002000690A2/en
Priority claimed from PCT/US2001/021066 external-priority patent/WO2002008288A2/en
Priority claimed from PCT/US2001/021735 external-priority patent/WO2002008284A2/en
Priority to AU2001286785A priority Critical patent/AU2001286785B2/en
Priority to MXPA03001643A priority patent/MXPA03001643A/en
Priority to KR1020037002672A priority patent/KR100607611B1/en
Priority to JP2002522275A priority patent/JP2004520810A/en
Application filed by Genentech Inc, Avi J Ashkenazi, Audrey Goddard, Paul J Godowski, Austin L Gurney, Paul Polakis, P Mickey Williams, William I Wood, Thomas D Wu, Zemin Zhang filed Critical Genentech Inc
Priority to AU8678501A priority patent/AU8678501A/en
Priority to EP01966255A priority patent/EP1311668A2/en
Priority to CA002420193A priority patent/CA2420193A1/en
Publication of WO2002016602A2 publication Critical patent/WO2002016602A2/en
Publication of WO2002016602A3 publication Critical patent/WO2002016602A3/en
Priority to AU2006230703A priority patent/AU2006230703A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/645—Polycationic or polyanionic oligopeptides, polypeptides or polyamino acids, e.g. polylysine, polyarginine, polyglutamic acid or peptide TAT
    • A61K47/6455—Polycationic oligopeptides, polypeptides or polyamino acids, e.g. for complexing nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Abstract

The present invention is directed to compositions of matter useful for the diagnosis and treatment of tumor in mammals and to methods of using those compositions of matter for the same.
PCT/US2001/026626 2000-08-24 2001-08-23 Compositions and methods for the diagnosis and treatment of tumor WO2002016602A2 (en)

Priority Applications (8)

Application Number Priority Date Filing Date Title
CA002420193A CA2420193A1 (en) 2000-08-24 2001-08-23 Compositions and methods for the diagnosis and treatment of tumor
EP01966255A EP1311668A2 (en) 2000-08-24 2001-08-23 Compositions and methods for the diagnosis and treatment of tumor
AU8678501A AU8678501A (en) 2000-08-24 2001-08-23 Compositions and methods for the diagnosis and treatment of tumor
AU2001286785A AU2001286785B2 (en) 2000-08-24 2001-08-23 Compositions and methods for the diagnosis and treatment of tumor
JP2002522275A JP2004520810A (en) 2000-08-24 2001-08-23 Compositions and methods for tumor diagnosis and treatment
KR1020037002672A KR100607611B1 (en) 2000-08-24 2001-08-23 Compositions and methods for the diagnosis and treatment of tumor
MXPA03001643A MXPA03001643A (en) 2000-08-24 2001-08-23 Compositions and methods for the diagnosis and treatment of tumor.
AU2006230703A AU2006230703A1 (en) 2000-08-24 2006-10-18 Compositions and methods for the diagnosis and treatment of tumor

Applications Claiming Priority (14)

Application Number Priority Date Filing Date Title
USPCT/US00/23328 2000-08-24
PCT/US2000/023328 WO2001016318A2 (en) 1999-09-01 2000-08-24 Secreted and transmembrane polypeptides and nucleic acids encoding the same
USPCT/US00/32678 2000-12-01
PCT/US2000/032678 WO2001040466A2 (en) 1999-12-01 2000-12-01 Secreted and transmembrane polypeptides and nucleic acids encoding the same
USPCT/US01/06520 2001-02-28
PCT/US2001/006520 WO2001068848A2 (en) 2000-03-01 2001-02-28 Secreted and transmembrane polypeptides and nucleic acids encoding the same
PCT/US2001/017800 WO2001093983A1 (en) 2000-06-02 2001-06-01 Secreted and transmembrane polypeptides and nucleic acids encoding the same
USPCT/US01/17800 2001-06-01
PCT/US2001/019692 WO2002000690A2 (en) 2000-06-23 2001-06-20 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
USPCT/US01/19692 2001-06-20
PCT/US2001/021066 WO2002008288A2 (en) 2000-07-20 2001-06-29 Secreted and transmembrane polypeptides and nucleic acids encoding the same
USPCT/US01/21066 2001-06-29
PCT/US2001/021735 WO2002008284A2 (en) 2000-07-20 2001-07-09 Compositions and methods for the diagnosis and treatment of disorders involving angiogenesis
USPCT/US01/21735 2001-07-09

Publications (2)

Publication Number Publication Date
WO2002016602A2 WO2002016602A2 (en) 2002-02-28
WO2002016602A3 true WO2002016602A3 (en) 2003-02-06

Family

ID=27567433

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/026626 WO2002016602A2 (en) 2000-08-24 2001-08-23 Compositions and methods for the diagnosis and treatment of tumor

Country Status (5)

Country Link
JP (1) JP2004520810A (en)
AU (2) AU8678501A (en)
CA (1) CA2420193A1 (en)
MX (1) MXPA03001643A (en)
WO (1) WO2002016602A2 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050123925A1 (en) * 2002-11-15 2005-06-09 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
NZ535925A (en) * 2002-04-16 2008-06-30 Genentech Inc An isolated antibody that binds to a particular polypeptide
EP2305710A3 (en) 2002-06-03 2013-05-29 Genentech, Inc. Synthetic antibody phage libraries
EP1546182B1 (en) * 2002-09-11 2011-01-05 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
JP2006516192A (en) * 2002-10-18 2006-06-29 ジェネンテック・インコーポレーテッド Compositions and methods for tumor diagnosis and treatment
CA2511013A1 (en) * 2002-12-20 2004-07-15 Biogen Idec Ma Inc. Multivalent lymphotoxin beta receptor agonists and therapeutic uses thereof
CA2530884C (en) 2003-07-02 2016-01-12 Genentech, Inc. Trp-p8 active compounds and therapeutic treatment methods
ZA200610273B (en) 2004-07-02 2008-06-25 Genentech Inc Compositions and methods for treatment of non-hodgkin's lymphoma
JP4547533B2 (en) * 2004-12-15 2010-09-22 独立行政法人産業技術総合研究所 Nucleolytic enzyme
JPWO2006082851A1 (en) * 2005-02-02 2008-06-26 国立大学法人 東京大学 Epiglycanin related mucin
IL282783B2 (en) * 2006-05-18 2023-09-01 Caris Mpi Inc System and method for determining individualized medical intervention for a disease state
WO2009015842A2 (en) * 2007-07-27 2009-02-05 Immatics Biotechnologies Gmbh Novel immunogenic epitopes for immunotherapy
WO2009080829A1 (en) 2007-12-26 2009-07-02 Biotest Ag Agents targeting cd138 and uses thereof
SI2242772T1 (en) 2007-12-26 2015-03-31 Biotest Ag Immunoconjugates targeting cd138 and uses thereof
CN101945892B (en) 2007-12-26 2017-11-24 生物测试股份公司 For the method and reagent of the targeting for improving the tumour cell to expressing CD138
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0388914A1 (en) * 1989-03-24 1990-09-26 BEHRINGWERKE Aktiengesellschaft Monoclonal antibodies against tumor associated antigen, their preparation and use
WO1999040189A2 (en) * 1998-02-09 1999-08-12 Genset Cdnas encoding secreted proteins
WO1999046281A2 (en) * 1998-03-10 1999-09-16 Genentech, Inc. Novel polypeptides and nucleic acids encoding the same
WO2000012708A2 (en) * 1998-09-01 2000-03-09 Genentech, Inc. Further pro polypeptides and sequences thereof
WO2000023108A1 (en) * 1998-10-19 2000-04-27 Diadexus Llc Method of diagnosing, monitoring, staging, imaging and treating prostate cancer

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0388914A1 (en) * 1989-03-24 1990-09-26 BEHRINGWERKE Aktiengesellschaft Monoclonal antibodies against tumor associated antigen, their preparation and use
WO1999040189A2 (en) * 1998-02-09 1999-08-12 Genset Cdnas encoding secreted proteins
WO1999046281A2 (en) * 1998-03-10 1999-09-16 Genentech, Inc. Novel polypeptides and nucleic acids encoding the same
WO2000012708A2 (en) * 1998-09-01 2000-03-09 Genentech, Inc. Further pro polypeptides and sequences thereof
WO2000023108A1 (en) * 1998-10-19 2000-04-27 Diadexus Llc Method of diagnosing, monitoring, staging, imaging and treating prostate cancer

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
R. CHARI ET AL.: "Immunoconjugates containing novel maytansinoids: promising anticancer drugs.", CANCER RESEARCH, vol. 52, no. 1, 1 January 1992 (1992-01-01), Baltimore, MD, USA, pages 127 - 131, XP000453560 *
See also references of EP1311668A2 *

Also Published As

Publication number Publication date
CA2420193A1 (en) 2002-02-28
MXPA03001643A (en) 2004-05-14
WO2002016602A2 (en) 2002-02-28
JP2004520810A (en) 2004-07-15
AU8678501A (en) 2002-03-04
AU2001286785B2 (en) 2006-08-17

Similar Documents

Publication Publication Date Title
EP1445317A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003024392A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003000113A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2003088808A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2006110760A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2002016581A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2006029183A3 (en) Compositions and methods for the diagnosis and treatment of tumor
MXPA05005107A (en) Compositions and methods for the diagnosis and treatment of tumor.
WO2004112829A3 (en) Compositions and methods for the diagnosis and treatment of tumors of glial origin
EP2067472A8 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2007001851A3 (en) Compositions and methods for the diagnosis and treatment of tumor
AU6147401A (en) Compositions and methods for the treatment of cancer
WO2002016602A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2005049075A3 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
AU3227700A (en) Skin sanitizing compositions
WO2004024063A3 (en) Compositions and methods for the diagnosis and treatment of tumor
WO2005063299A3 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
WO2004096124A3 (en) Compositions and methods for the diagnosis and treatment of tumor
AU2001283199A1 (en) Methods and compositions for the diagnosis and treatment of brown adipose cell disorders
MXPA03001644A (en) Compositions and methods for the diagnosis and treatment of tumor.
AU2001255730A1 (en) Methods and compositions for the treatment of cardiac indications
MXPA05008293A (en) Compositions and methods for the diagnosis and treatment of tumor.
WO2004019857A3 (en) Achaete-scute like-2 polypeptides and encoding nucleic acids and methods for the diagnosis and treatment of tumor
WO2003053334A3 (en) Compositions and methods for the diagnosis and treatment of tumor
AU6871501A (en) Cgi-69 compositions and methods of use

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001286785

Country of ref document: AU

WWE Wipo information: entry into national phase

Ref document number: 2003/01205

Country of ref document: ZA

Ref document number: 200301205

Country of ref document: ZA

WWE Wipo information: entry into national phase

Ref document number: 2420193

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: PA/a/2003/001643

Country of ref document: MX

Ref document number: 2002522275

Country of ref document: JP

Ref document number: 1020037002672

Country of ref document: KR

WWE Wipo information: entry into national phase

Ref document number: 2001966255

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1020037002672

Country of ref document: KR

WWP Wipo information: published in national office

Ref document number: 2001966255

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWG Wipo information: grant in national office

Ref document number: 1020037002672

Country of ref document: KR